structurebaseddrugdesignofanovelfamilyofchalconesaspparagonistsvirtualscreeningsynthesisandbiologicalactivitiesinvitro1

	structurebaseddrugdesignofanovelfamilyofchalconesaspparagonistsvirtualscreeningsynthesisandbiologicalactivitiesinvitro1
	Xianghua LI; Hanjun ZOU; Anhui WU; Yangliang YE; Jianhua SHEN
刊名	actapharmacologicasinica
	2007
卷号	28 期号:12 页码:2040
关键词	peroxisome proliferator-activated receptors drug design virtual screening
ISSN号	1671-4083
英文摘要	Aim: To design and synthesize a novel class of peroxisome proliferator-activated receptors (PPAR)α agonists, which is obtained by the combination of the classical fibrate "head group", a linker with appropriate length and a chalcone. Methods: Thirty seven compounds were designed and identified employing the virtual screening approach. Six compounds were then selected for synthesis and bioassay according to the virtual screening results, structural similarity, and synthetic complexity. Results: Six new compounds (4b and 4d-h) were synthesized and bioassayed. All were found to be potent PPARα agonists, compound 4 h being the most prominent with a 50% effective concentration value of 0.06 μmol/L. Conclusion: This study provides a promising novel family of chalcones with a potential hypolipidemic effect.
语种	英语
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/284682]
专题	中国科学院上海药物研究所
作者单位	中国科学院上海药物研究所
推荐引用方式 GB/T 7714	Xianghua LI,Hanjun ZOU,Anhui WU,et al. structurebaseddrugdesignofanovelfamilyofchalconesaspparagonistsvirtualscreeningsynthesisandbiologicalactivitiesinvitro1[J]. actapharmacologicasinica,2007,28(12):2040.
APA	Xianghua LI,Hanjun ZOU,Anhui WU,Yangliang YE,&Jianhua SHEN.(2007).structurebaseddrugdesignofanovelfamilyofchalconesaspparagonistsvirtualscreeningsynthesisandbiologicalactivitiesinvitro1.actapharmacologicasinica,28(12),2040.
MLA	Xianghua LI,et al."structurebaseddrugdesignofanovelfamilyofchalconesaspparagonistsvirtualscreeningsynthesisandbiologicalactivitiesinvitro1".actapharmacologicasinica 28.12(2007):2040.